查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1136913

2022-2029 年患者登记软件的全球市场

Global Patient Registry Software Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

患者註册软件市场的增长受到政府举措、越来越多地采用患者註册软件来诊断疾病以及研发活动的推动。

电子健康记录 (EHR) 的接受度有望推动市场增长。

在数字世界中，信息和通信技术在医疗保健行业中得到广泛应用，以处理大数据和海量健康信息。根据国际标准化组织 (ISO) 的规定，EHR 被认为是数字形式的患者数据存储库，可以安全地存储和交换，并且可供多个授权用户访问。在医疗保健部门采用该系统将改善患者护理、最小化成本、增加收入、减少医疗事故、降低文件空间要求、数据保密、患者数据的集中管理，它具有一些优势，例如共享医疗信息。此外，EHR 使临床医生能够轻鬆分析患者数据以发现新的治疗方法、发现安全问题并识别异常的临床发现。

此外，市场参与者正在采用各种营销策略，例如产品发布和合作。例如，2020 年 10 月，Dacima Software, Inc. 与 Movember 合作设计和开发了一个新的註册数据库，以启动世界上最大的前列腺癌患者註册网络。同样在 2020 年 6 月，ArborMetrix Inc.（美国）与介入放射学会（SIR）（美国）建立了合作伙伴关係。这种伙伴关係的目标是为 IR 质量登记处提供一种整合分析以改善患者护理的方法。

患者註册软件的高成本阻碍了市场增长

但是，全球超过 50% 的电子记录项目未能实现预期收益。 EHR 的实施仍然是一项重大挑战，尤其是在撒哈拉以南低收入国家的医疗保健部门。只有 15% 的低收入国家在医疗保健设施中拥有全国性的电子记录系统。

COVID-19 影响分析

COVID-19 的出现对全球患者註册软件市场产生了重大影响。自 COVID-19 流行开始以来，由于其复杂和不确定的性质，COVID-19 的迅速而令人震惊的爆发已经在全球范围内产生了对数据收集基础设施的基本需求。从事开发数据管理解决方案的市场参与者。例如，2020 年 3 月，数据和分析技术与服务提供商 Health Catalyst, Inc. 推出了 COVID-19 註册表、仪表板和容量规划工具。此外，政府正在帮助控制和管理 COVID-19 的情况。例如，在伊朗，在 COVID-19 流行初期，卫生系统管理员卫生部创建了两个信息系统来处理卫生保健中心的 COVID-19。但是，这两个系统会收集有关 COVID-19 患者的基本信息。总体而言，COVID-19 对市场增长产生了积极影响。

全球患者註册软件市场报告将提供对大约 65 多个市场数据表、65 多个数字和 200 多页（大约）的访问。

内容

第一章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 越来越多地采用 EHR 和信息技术相关服务
      • 随着慢性病的增加，医疗保健管理变得更加复杂
    • 约束因素
      • 隐私、数据安全相关问题、缺乏熟练和训练有素的资源
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章。按疾病登记类型

  • 阿尔茨海默氏症
  • 糖尿病
  • 骨科
  • 心脏病学
  • 癌症
  • 其他

第 8 章按功能类型

  • 患者护理管理
  • 健康信息交换 (HIC)
  • 护理点 (POC)
  • 调查研究
  • 其他

第 9 章，最终用户

  • 医院
  • 製药公司
  • 实验室
  • 其他

第 10 章按软件类型

  • 综合型
  • 独立

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按治疗类型划分的基准

第 13 章公司简介

  • 达西玛软件公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • McKesson Corporation
  • Global Vision Technologies Inc.
  • ImageTrend Inc.
  • Liaison Technologies.
  • Optum Inc.
  • Phytel Inc.
  • Quintiles IMS Holdings Inc

第 14 章全球患者登记软件市场-M

简介目录
Product Code: DMHCIT825

Market Overview

Patient Registry Software Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 9.2% during the forecast period (2022-2029).

Patient registry software is an automated database containing personal, medical, social, and financial data reported by healthcare professionals or patients. In addition, this software easily collects data on patients or groups of patients in clinical studies, taking a new drug or having a particular diagnosis or condition.

Market Dynamics

The patient registry software market growth is driven by government initiatives, the rising adoption of patient registry softwares for the diagnosis of disease, increase and research and development activities.

The acceptance of Electronic Health Records (EHR) is expected to drive the market growth

In the digital world, information communication technologies are commonly used and extensive in the healthcare industry to handle big data and ample health information. According to the International Organization for Standardization (ISO), EHR is considered a repository of patient data in digital form, stored and exchanged securely and accessible by multiple authorized users. Adopting this system in the healthcare sector has several advantages, such as improving patient care, minimizing cost, increasing revenue, reducing medical errors, reducing the need for file space, data confidentiality, central patient data management, and sharing medical information. In addition, the EHR enables clinicians to easily analyze patient data to discover new treatments, uncover safety issues, and identify unusual clinical findings.

In addition, the market players are adopting different market strategies, including product launches and collaboration. For instance, in October 2020, Dacima Software, Inc., with Movember, designed and developed a new registry database to launch the world's largest prostate cancer patient registry network. Also, in June 2020, ArborMetrix Inc. (US) partnered with The Society of Interventional Radiology (SIR) (US). This partnership goal is to provide the IR Quality Registry with a way to improve patient care by integrating analytics.

The high cost of Patient Registry Software will hamper the growth of the market

However, more than 50% of electronic record projects worldwide failed without providing their targeted benefits. Especially the implementation of EHR remains a major challenge in the healthcare sector in low-income countries such as Sub-Saharan countries. Merely 15% of low-income countries have nationally adopted electronic record systems in health institutions.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global patient registry software market. From the beginning of the COVID-19 pandemic, the fast and surprising outbreak of COVID-19, its complex and unspecified nature has created data collection infrastructures and has become a fundamental necessity worldwide. The market players engaged in developing solutions for the management of data. For instance, in March 2020, Health Catalyst, Inc., a provider of data and analytics technology and services, launched a COVID-19 Registry, Dashboard, and Capacity Planning Tool. In addition, the government supports controlling and managing the situation of COVID-19. For instance, in Iran, at the beginning of the COVID-19 epidemic, the Ministry of Health, as the custodian of the health system, created two information systems for addressing COVID-19 in healthcare centers. However, these two systems collect basic information about patients with COVID-19. Overall, COVID-19 positively impacted market growth.

Segment Analysis

The Point Of Care (POC) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The Point Of Care (POC) segment is expected to boost the market over the forecast period. As per the article published in Practical Laboratory Medicine in November 2020, Accreditation and regulatory standards highlight the rising need to integrate POC Testing results into the patient's electric medical records. This promotes accessibility of POC results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POC results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurement, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POC results should also be differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POC is routine in all hospitals and has become the standard for patient care in various healthcare settings.

Geographical Analysis

North America region holds the largest market share of the global patient registry software market

North America dominates the market for Patient Registry Software and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to increasing government support for the development, advanced healthcare infrastructure and point-of-care management. The development of digital infrastructure in the healthcare sector and the adoption of technological advancements by healthcare professionals and staff drive the market in the North American region.

For instance, in April 2020, the American Heart Association declared the development of a new patient registry to collect data. It helps the researchers to understand the interconnection between coronavirus, cardiovascular diseases, and related treatment protocols. Also, in February 2021, the Leukemia & Lymphoma Society (LLS) partnered with Citizen to develop a digital health solution to study the relationship between coronavirus and vaccination amongst blood cancer patients. They established LLS National Patient Registry to collect data on blood cancer patients for the study.

In addition, the market players are adopting product launches and collaboration strategies to expand their business in the North American region. For instance, in March 2021, ESO Solutions partnered with Virginia EMS Systems to deliver a statewide EMS data repository and statewide trauma registry to collect and analyze data to reveal key insights and trends. Also, in November 2020, ArborMetrix, Inc. partnered with the American Academy of Pediatrics to develop and grow a clinical registry to advance all children's health, well-being, and development.

Competitive Landscape

The patient registry software market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Dacima Software Inc, McKesson Corporation, Global Vision Technologies Inc., ImageTrend Inc., Liaison Technologies, Optum Inc., Phytel Inc., and Quintiles IMS Holdings Inc, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global patient registry software market.

For instance,

  • In December 2020, ImageTrend, Inc. announced the latest National Trauma Data Bank (NTDB) Data Dictionary available in the Patient Registry on January 2021.

Dacima Software Inc

Overview:

Dacima Software is a flexible company founded in 2003 and has developed advanced clinical software that helps solve the business's major strategic and operational challenges.

Product Portfolio:

DACIMA REGISTRY: The Dacima REGISTRY is a modified database creation software that permits users to produce registries and administrative databases without expertise in computer programming or database design theory.

The global Patient Registry Software market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase In Adoption Of EHR's And Information Technology Related Services
      • 4.1.1.2. Increase In The Prevalence Of The Chronic Disease Lead To Advancements In Healthcare Management
    • 4.1.2. Restraints:
      • 4.1.2.1. Privacy, Data Security-Related Issues And Lack Of Availability Of Skilled & Trained Resources
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Disease Registry Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 7.1.2. Market Attractiveness Index, By Disease Registry Type
  • 7.2. Alzheimer's Disease *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Diabetes
  • 7.4. Orthopaedics
  • 7.5. Cardiovascular
  • 7.6. Cancer
  • 7.7. Others

8. By Functionality Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 8.1.2. Market Attractiveness Index, By Functionality Type
  • 8.2. Patient Care Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Health Information Exchange (HIC)
  • 8.4. Point Of Care (POC)
  • 8.5. Research
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pharmaceutical companies
  • 9.4. Clinical laboratories
  • 9.5. Others

10. By Software Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 10.1.2. Market Attractiveness Index, By Software Type
  • 10.2. Integrated*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Stand-alone

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Treatment type Benchmarking

13. Company Profiles

  • 13.1. Dacima Software Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. McKesson Corporation
  • 13.3. Global Vision Technologies Inc.
  • 13.4. ImageTrend Inc.
  • 13.5. Liaison Technologies.
  • 13.6. Optum Inc.
  • 13.7. Phytel Inc.
  • 13.8. Quintiles IMS Holdings Inc

LIST NOT EXHAUSTIVE

14. Global Patient Registry Software market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us